期刊文献+

脊肌萎缩症治疗研究进展 被引量:1

下载PDF
导出
作者 刘宇 李洪
机构地区 解放军第
出处 《现代中西医结合杂志》 CAS 2010年第15期1926-1928,共3页 Modern Journal of Integrated Traditional Chinese and Western Medicine
  • 相关文献

参考文献21

  • 1Chung B,Wong V,Ip P.Prevalence spinalmuscular diseases in Chinese children:a study in southern China[J].J Child Neurol,2003,18(3):217-219.
  • 2杨晓苏,张丽芳,肖波.SMN蛋白与脊髓性肌萎缩症的研究进展[J].中国神经科学杂志,2002,18(4):740-742. 被引量:3
  • 3吴志国,杨晓苏,肖波.运动神经元生存蛋白及其相互作用蛋白研究进展[J].中华医学遗传学杂志,2003,20(5):430-432. 被引量:2
  • 4王洁,王治平.儿童脊肌萎缩症诊治新进展[J].诊断学理论与实践,2007,6(3):281-283. 被引量:2
  • 5Wirth B,Brichta L,Hahnen E.Spinal muscular atrophy and theraprutic prospects[J].Prog Mol Subcell Biol,2006,44:109-132.
  • 6Iannaccone ST,Smith SA,Simard LR.Spinalmuscular atrophy[J].Curr Neuro Neurosci Rep,2004,4(1):74-80.
  • 7Monani UR,Lorson CL,Parsons DW,et al.A single nucleotide difference that alter spilcing patterns distinguishes the SMA gene SMN1 from the copy SMN2[J].Hum Mol Genet,1999,8:1177-1183.
  • 8Lorson CL,Androphy EJ.An exonic enhancer is required for inclusion of an essential exon in the SMA-determining gene SMN[J].Hum Mol Genet,2000,9:259-265.
  • 9唐丽琴,魏伟.组蛋白去乙酰化酶抑制剂与炎症免疫性疾病[J].中国药理学通报,2007,23(1):1-4. 被引量:5
  • 10Amy MA,Barrington GB,Addis AT,et al.Trichostatin A increase SMN expression and survival in a mouse model of spinal muscular atrophy[J].J Clin Inves,2007,117(3):659-671.

二级参考文献157

共引文献16

同被引文献23

  • 1Meldrum C, Scott C, Swoboda KJ. Spinal muscular atro- phy genetic counseling access and genetic knowledge: par ents'perspestiveseJ. J Child Neurol, 2007,22 (8) : 1019 1026.
  • 2Aesadi G, Li X, Murphy K J, et al. Alpha-synuclein loss in spinal muscular atrophy[J]. J Mol Neurosci, 2011,43 (3) : 275-283.
  • 3Alias L,Bernal S, Fuentes Prior P, et al. Mutation update of spinal muscular atrophy in Spain: molecular character- ization of 745 unrelated patients and identification of four novel mutations in the SMN1 gene[J]. Hum Genet,2009, 125(1) :29-39.
  • 4Zhang Y,Huang JJ,Wang ZQ,et al. Value of muscle en- zyme measurement in evalualing different neuromuscular diseases[J]. Clin Chim Acta,2012,413(3/4) :520-524.
  • 5Brahe C, Servidei S, Zappata S, et al. Genetic homogeneity be tween childhood-onset and adult-onset autosomal recessive spinal muscular atrophy[J]. Lancet, 1995,346 (8977) : 741- 742.
  • 6Zerres K, Rudnik SS, Forker R, et al. Genetic basis of a- dult-onset spinal muscular atrophy[J]. Lancet, 1995,346 (8983) :1162.
  • 7Martin Y, Valero A, del Castillo E, et al. Genetic study of SMA patients without homozygous SMN1 deletions:iden- tification of compound heterozygotes and characterization of novel intragenic SMN1 mutation [J]. Hum Genet,2002,110(3):257-263.
  • 8Oskoui M,Kaufmann P. Spinal muscular atrophy[J]. Neuro- therapeutics, 2008,5 (4) : 499-506.
  • 9Mereuri E,Bertini E,Messina S,et al. Pilot trial of pheny- lbutyrate in spinal muscular atrophy [J]. Neuromuscul Disord,2004,14(2) :130- 135.
  • 10Kathryn JS,Charles BS,Sandra PR, et al. Phase II open label study of valproic acid in spinal muscular atrophy [J]. PLoS ONE, 2009,4 (5) : e5268.

引证文献1

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部